Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petco Health & Wellness Company (WOOF) Current Deferred Revenue (2021 - 2026)

Petco Health & Wellness Company's Current Deferred Revenue history spans 6 years, with the latest figure at $31.4 million for Q1 2026.

  • For Q1 2026, Current Deferred Revenue rose 6.37% year-over-year to $31.4 million; the TTM value through Jan 2026 reached $31.4 million, up 6.37%, while the annual FY2026 figure was $31.4 million, 6.37% up from the prior year.
  • Current Deferred Revenue reached $31.4 million in Q1 2026 per WOOF's latest filing, up from $29.6 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $33.5 million in Q1 2024 to a low of $18.0 million in Q1 2022.
  • Average Current Deferred Revenue over 5 years is $27.1 million, with a median of $29.6 million recorded in 2025.
  • Peak YoY movement for Current Deferred Revenue: surged 45.47% in 2024, then fell 11.81% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $18.0 million in 2022, then rose by 28.01% to $23.0 million in 2023, then soared by 45.47% to $33.5 million in 2024, then decreased by 11.81% to $29.6 million in 2025, then increased by 6.37% to $31.4 million in 2026.
  • Per Business Quant, the three most recent readings for WOOF's Current Deferred Revenue are $31.4 million (Q1 2026), $29.6 million (Q1 2025), and $33.5 million (Q1 2024).